Clinical trials
Prediction clinical trials
Below are recruiting prediction clinical trials, each written for real people, not researchers. We’re tracking 1,080 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06224283Recruiting
Predicting desmoid tumor growth after cryoablation
This study looks at whether a special MRI analysis (radiomics) can better predict if a desmoid tumor will grow back after freezing treatment (cryoablation) compared to standard methods. It may help doctors decide on future treatment steps.
BolognaAges Any age - NCT06207084Recruiting
Home exercise program for people with physical disabilities
This study tests a home-based exercise program for people with permanent physical disabilities that limit mobility. The goal is to see if coaching and training sessions can help you become more active and improve your health.
Birmingham, AlabamaAges 18–89 - NCT06227728Recruiting
Predicting immunotherapy response in advanced cancer
This study uses blood and tumor samples to find markers that predict whether immunotherapy will work for people with stage IV cancer. The goal is to better match treatments to patients.
Ho Chi Minh City, Hồ Chí MinhAges 18–80 - NCT06197776Recruiting
Predicting treatment success for advanced nasopharyngeal cancer
This study uses advanced testing (multi-omics) to predict if combining chemoradiation with immunotherapy works better for nasopharyngeal cancer that has returned or spread. It aims to find the right treatment for each person.
Guangzhou, GuangdongAges 18–70 - NCT06204926Recruiting
AI predicts SMILE surgery results and risks
This trial tests if an AI program can predict complications and recovery after SMILE eye surgery for nearsightedness. It may help you understand your risks if you are a candidate for this surgery.
Nanchang, JiangxiAges 18–45 - NCT06206369Recruiting
Ai tool for predicting vascular disease risk
This study is collecting medical information from people with abdominal aortic aneurysms or peripheral artery disease to build an AI tool that can better predict how these conditions progress. The goal is to help doctors give more personalized care.
HelsinkiAges 40–90 - NCT06157060Recruiting
Predicting liver cancer return after surgery with a blood test
This trial is for people with early-stage liver cancer who are scheduled for surgery. It uses a simple blood test to look for tiny bits of tumor DNA after treatment, which may help predict if the cancer will come back.
Foshan, GuangdongAges 18–75 - NCT06179303RecruitingPhase 2
Imaging to predict response to abemaciclib for advanced breast cancer
This trial tests if a special PET scan can predict how well the drug abemaciclib works for people with advanced hormone receptor-positive, HER2-negative breast cancer. If you qualify, you would receive abemaciclib and have imaging scans to see if your cancer responds.
St Louis, MissouriAges 18 years+ - NCT06162884Recruiting
Using one scan to predict early scarred lung disease
This study uses a single lung scan to find early signs of progressive scarring (fibrosis) in people with pulmonary fibrosis. It may help doctors predict which patients will get worse faster.
Los Angeles, CaliforniaAges 18 years+ - NCT06153056Recruiting
Predicting success of stomach sleeve procedure
This study looks at factors that predict weight loss success after a non-surgical stomach reduction procedure (endoscopic sleeve gastroplasty). It may help if you have obesity-related health problems and have not succeeded with diet or lifestyle changes.
ParisAges 18 years+ - NCT06144151Recruiting
Pupil check to predict CAR-T brain side effects
This study tests if checking your pupil size with a small light device can predict brain-related side effects from CAR-T cell therapy. It is for patients with certain lymphomas receiving axi-cel CAR-T treatment in the hospital.
Houston, TexasAges 18 years+ - NCT06106191Recruiting
Mindfulness program for chronic low back pain
This trial tests a mindfulness-based program designed to help people with long-term low back pain. It aims to see if combining mindfulness with a personalized approach can improve pain management and daily functioning.
Boston, MassachusettsAges 18 years+ - NCT06098560Recruiting
ctDNA as a marker for immunotherapy in advanced colorectal cancer
This study looks at whether a blood test for tumor DNA (ctDNA) can predict how well immunotherapy works in people with advanced or locally advanced colorectal cancer that has specific genetic features (dMMR/MSI-H). If you qualify, the trial will monitor your ctDNA levels while you receive standard immunotherapy to see if changes in those levels can show early on if the treatment is working.
Beijing, Beijing MunicipalityAges 18–80 - NCT06051214Recruiting
Predicting blood clots in cancer patients at risk
This trial studies how your blood's ability to clot changes over time in people with certain cancers who have not yet started treatment. The goal is to better predict who might develop a dangerous blood clot, so that preventative steps can be taken.
Saint-HerblainAges 18 years+ - NCT06048510Recruiting
New blood markers to predict pregnancy diabetes and large babies
This study tests if new blood markers can help predict gestational diabetes and the risk of having a large baby. It could lead to earlier detection and better care.
BordeauxAges 18–99 - NCT06054360Recruiting
Predicting irregular heartbeat after heart bypass surgery
This study uses an ultrasound test of the heart's right atrium to see if it can predict who will develop an irregular heartbeat (atrial fibrillation) after planned coronary bypass surgery. If you are scheduled for this surgery and have no history of atrial fibrillation, you may be able to join.
AmiensAges 18 years+ - NCT03408964Recruiting
Blood tests to predict treatment response in prostate cancer
This study checks whether certain blood markers can help predict how well people with prostate cancer will respond to therapy. It may help doctors choose the most effective treatment sooner by using information from your blood.
BellinzonaAges 18 years+ - NCT06017557Recruiting
Predicting surgery results for advanced ovarian cancer
This study looks at results from surgery to remove as much advanced ovarian cancer as possible after chemotherapy. Participating hospitals are in Italy and Canada.
RomaAges 18 years+ - NCT06022458Recruiting
Pregnancy ultrasound to predict placenta health
This study looks at ultrasound images of the placenta taken during pregnancy to see if they can predict how well the placenta works or what it looks like under a microscope. It may help doctors understand more about pregnancy complications like fetal growth restriction.
Evanston, IllinoisAges 18–60 - NCT06014112Recruiting
Glucose monitor test for heart attack recovery
This study tests a continuous glucose monitor (FSL Pro iQ) in people with heart attack to see if blood sugar patterns can predict recovery. It may help doctors better manage your care after a heart attack.
BéziersAges 18–85 - NCT06002100Enrolling by invitation
Predicting depression treatment response with brain imaging
This study uses a special headband (TD-fNIRS) that measures brain activity to see if it can predict how well different depression treatments work. You would be starting a new treatment for depression (like ketamine, SPRAVATO, TMS, or antidepressants) and wear the headband before and during treatment.
Costa Mesa, CaliforniaAges 18–75 - NCT05978557Recruiting
Brain tumor drug testing using live tissue samples
This trial uses a small piece of your brain tumor after surgery to test which drugs might work best for you. It helps doctors find the most effective treatment for your specific tumor.
Chapel Hill, North CarolinaAges Any age - NCT05999851Recruiting
Maternal blood vessel health in pregnancy
This study looks at how well your blood vessels work during pregnancy to help predict high blood pressure disorders. If you join, you will have extra monitoring and blood tests.
BolognaAges 18–65 - NCT05983991Recruiting
Study of GATA2 gene changes over time
This study looks at how GATA2 gene changes affect your blood cells over time. It is for people of any age who have a GATA2 mutation they were born with, and it does not test a new drug—just collects information and samples during regular checkups.
AngersAges Any age
Hear when a new Prediction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for prediction?
- Yes. Clin2 currently lists 1,080 recruiting prediction studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a prediction trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a prediction trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.